Porphyrin Centered Paclitaxel Tetrameric Prodrug Nanoassemblies as Tumor‐Selective Theranostics for Synergized Breast Cancer Therapy-Reference-Cited by-同舟云学术

Porphyrin Centered Paclitaxel Tetrameric Prodrug Nanoassemblies as Tumor‐Selective Theranostics for Synergized Breast Cancer Therapy

Published:2022-10-26 Issue:2 Volume:12 Page:2202024
ISSN:2192-2640
Container-title:Advanced Healthcare Materials
language:en
Short-container-title:Adv Healthcare Materials

Author:

Ma Xiaodong¹²³,Wang Pengfei¹²,Wu Qiwei⁴,Zhou Junnian³,Wang Dongqing⁴,Yadav Deependra¹³,Zhang Hongbo³,Zhang Yuezhou¹²^ORCID

Affiliation:

1. Xi'an Institute of Flexible Electronics (IFE) and Xi'an Institute of Biomedical Materials & Engineering (IBME) Northwestern Polytechnical University 127 West Youyi Road Xi'an 710072 China

2. Ningbo Institute of Northwestern Polytechnical University Frontiers Science Center for Flexible Electronics (FSCFE) Key laboratory of Flexible Electronics of Zhejiang Province Ningbo Institute of Northwestern Polytechnical University 218 Qingyi Road Ningbo 315103 China

3. Pharmaceutical Sciences Laboratory Faculty of Science and Engineering Åbo Akademi University Helsinki FI‐00520 Finland

4. Department of Radiology Affiliated Hospital of Jiangsu University Zhenjiang 212001 China

Funder

Northwestern Polytechnical University

Natural Science Foundation of Ningbo

Jiangsu Provincial Key Research and Development Program

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biomaterials

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adhm.202202024